--- title: "Balchem (NASDAQ:BCPC) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS" description: "Balchem Corporation (NASDAQ: BCPC) reported quarterly earnings of $1.27 per share, exceeding analysts' expectations of $1.25 by $0.02. The company generated revenue of $255.47 million, surpassing esti" type: "news" locale: "en" url: "https://longbridge.com/en/news/251341520.md" published_at: "2025-08-03T13:47:26.000Z" --- # Balchem (NASDAQ:BCPC) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS > Balchem Corporation (NASDAQ: BCPC) reported quarterly earnings of $1.27 per share, exceeding analysts' expectations of $1.25 by $0.02. The company generated revenue of $255.47 million, surpassing estimates of $250.31 million, and achieved a net margin of 14.48% with a return on equity of 12.41%. Revenue increased by 9.1% year-over-year. Balchem's stock opened at $152.17, with a market cap of $4.96 billion. Institutional investors hold 87.91% of the company's shares, and recent analyst ratings include a downgrade from "buy" to "hold." Balchem (NASDAQ:BCPC - Get Free Report) posted its quarterly earnings results on Thursday. The basic materials company reported $1.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.25 by $0.02, Zacks reports. The business had revenue of $255.47 million for the quarter, compared to analyst estimates of $250.31 million. Balchem had a return on equity of 12.41% and a net margin of 14.48%. The firm's revenue was up 9.1% on a year-over-year basis. During the same period last year, the company earned $1.09 EPS. ## Balchem Price Performance - Industrial Chemicals: 3 Stocks Poised for Growth in the New Year Shares of NASDAQ BCPC opened at $152.17 on Friday. The firm has a market cap of $4.96 billion, a P/E ratio of 34.90, a price-to-earnings-growth ratio of 3.29 and a beta of 0.89. Balchem has a 1-year low of $145.70 and a 1-year high of $185.96. The company has a current ratio of 2.64, a quick ratio of 1.40 and a debt-to-equity ratio of 0.18. The business's 50 day moving average is $160.02 and its 200-day moving average is $162.22. ## Institutional Investors Weigh In On Balchem A number of large investors have recently modified their holdings of BCPC. Advisors Asset Management Inc. bought a new position in Balchem during the 1st quarter worth $27,000. AQR Capital Management LLC boosted its stake in Balchem by 124.4% during the 1st quarter. AQR Capital Management LLC now owns 5,074 shares of the basic materials company's stock valued at $842,000 after purchasing an additional 2,813 shares during the last quarter. Jones Financial Companies Lllp boosted its stake in shares of Balchem by 1,768.2% in the 1st quarter. Jones Financial Companies Lllp now owns 822 shares of the basic materials company's stock worth $136,000 after buying an additional 778 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in shares of Balchem by 53.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 246,883 shares of the basic materials company's stock worth $40,983,000 after purchasing an additional 86,132 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Balchem by 9.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 100,860 shares of the basic materials company's stock worth $16,743,000 after purchasing an additional 9,118 shares during the period. Institutional investors and hedge funds own 87.91% of the company's stock. ## Wall Street Analyst Weigh In Several analysts recently issued reports on the company. Wall Street Zen lowered Balchem from a "buy" rating to a "hold" rating in a report on Saturday, July 26th. HC Wainwright set a $180.00 price objective on Balchem and gave the company a "buy" rating in a research note on Monday, April 28th. **Check Out Our Latest Analysis on BCPC** ## Balchem Company Profile (Get Free Report) Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. ## Featured Articles - Five stocks we like better than Balchem - How to Evaluate a Stock Before Buying - Is PG&E an AI Power Play? Why Options Traders Are Betting Big - What Makes a Stock a Good Dividend Stock? - MarketBeat Week in Review – 07/28 - 08/01 - Insider Buying Explained: What Investors Need to Know - Will Hims & Hers Fall Along With Novo Nordisk? *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.* ## Should You Invest $1,000 in Balchem Right Now? Before you consider Balchem, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Balchem wasn't on the list. While Balchem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [BCPC.US - Balchem](https://longbridge.com/en/quote/BCPC.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 拜切公司将出席 CJS 证券年度新年新思路虚拟会议 | Balchem 公司将于 2026 年 1 月 14 日参加 CJS Securities 第 26 届年度新年新想法虚拟会议。出席的主要代表包括 Ted Harris（董事长、总裁兼首席执行官）、Martin Bengtsson（首席财务 | [Link](https://longbridge.com/en/news/271329777.md) | | 欧盟对中国氯化胆碱进口产品征收反倾销税 | 欧盟对中国氯化胆碱进口征收了 90.0% 至 115.9% 的反倾销税，期限为五年，旨在保护其国内产业并确保供应链的稳定。新规防止通过第三国规避这一措施。拜切公司是受此法规影响的主要生产商 | [Link](https://longbridge.com/en/news/270494599.md) | | 拜切公司即将公布第四季度及全年财务业绩 | Balchem 公司将于 2026 年 2 月 20 日市场开盘前公布其 2025 年第四季度和全年财务业绩。会议电话将在东部时间上午 11:00 举行，由首席执行官 Ted Harris 和首席财务官 Martin Bengtsson 主 | [Link](https://longbridge.com/en/news/275121264.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.